The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706).
Lorenzo DragoLuigi CioffiMaria GiulianoMarco PaneAngela AmorusoIrene SchiavettiGregor ReidRiccardo Castagnolinull Propam Study GroupPublished in: Journal of immunology research (2022)
B632 (DSM 24706) were safe and significantly reduced by more than a third the frequency of asthma exacerbations. At present, the first-line treatment of asthma is still drug-based, but specific strains of probiotics may be auxiliary remedies.